Update of recent reforms in Germany to enhance the quality and efficiency of prescribing of proton pump inhibitors and lipid-lowering drugs

Pharmacoeconomics. 2009;27(5):435-8. doi: 10.2165/00019053-200927050-00010.
No abstract available

Publication types

  • Letter

MeSH terms

  • Drug Costs / legislation & jurisprudence*
  • Drug Costs / statistics & numerical data
  • Drug Prescriptions* / economics
  • Drug Prescriptions* / standards
  • Drug Prescriptions* / statistics & numerical data
  • Drugs, Generic / economics
  • Drugs, Generic / therapeutic use
  • Germany
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / economics*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Proton Pump Inhibitors / economics*
  • Proton Pump Inhibitors / therapeutic use*

Substances

  • Drugs, Generic
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Proton Pump Inhibitors